23 May 2013
Keywords: vaqta, hep, vaccine, effective, merck, co, hepatitis
Article | 19 July 1993
- Merck & Co's Vaqta hepatitis A vaccine confers immunity to 98% of
vacinees, according to data presented at the 8th Triennial International
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 July 1993
22 May 2013
© 2013 thepharmaletter.com